These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 4689897)

  • 1. In vitro demonstration of tumor-specific common antigens and embryonal antigens in murine fibrosarcomas induced by 7,12-dimethylbenz(a)anthracene.
    Ménard S; Colnaghi MI; Della Porta G
    Cancer Res; 1973 Mar; 33(3):478-81. PubMed ID: 4689897
    [No Abstract]   [Full Text] [Related]  

  • 2. Embryonic antigens shared between chemically induced lymphosarcomas and fibrosarcomas of the mouse.
    Ménard S; Colnaghi MI
    J Natl Cancer Inst; 1975 Feb; 54(2):479-81. PubMed ID: 1172784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of tumor antigen on maintenance versus depression of tumor-specific immunity.
    Vaage J
    Cancer Res; 1973 Mar; 33(3):493-503. PubMed ID: 4689898
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of murine oncofetal antigens as tumor-associated transplantation antigens.
    Chism SE; Wallis S; Burton RC; Warner NL
    J Immunol; 1976 Nov; 117(5 Pt.2):1870-7. PubMed ID: 993583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 6. Concomitant immunity and specific desensitization in murine tumor hosts.
    Vaage J
    Isr J Med Sci; 1973 Mar; 9(3):332-43. PubMed ID: 4710041
    [No Abstract]   [Full Text] [Related]  

  • 7. Common tumor-associated antigens of chemically induced mouse sarcomas expressing murine leukemia virus antigens by primary in vitro sensitization.
    Saito T
    Fukuoka Igaku Zasshi; 1984 Mar; 75(3):137-48. PubMed ID: 6088376
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro demonstration of cryosurgical augmentation of tumor immunity.
    Faraci RP; Bagley DH; Marrone J; Beazley RM
    Surgery; 1975 Mar; 77(3):433-8. PubMed ID: 1124499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of tumor-associated transplantation antigens in rat mammary tumors induced by 7,12-dimethylbenz (alpha) anthracene.
    Silinskas KC; Fang W; Mukkur TK
    Oncology; 1974; 29(4):273-82. PubMed ID: 4842402
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor-specific transplantation antigens in reticulum cell sarcomas and lymphomas induced by the friend virus complex.
    Fieldsteel AH; Dawson PJ; Kurahara C
    Cancer Res; 1973 Mar; 33(3):551-8. PubMed ID: 4347715
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ; Wunderlich JR; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
    Konda S; Smith RT
    Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
    [No Abstract]   [Full Text] [Related]  

  • 14. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
    Bendre AR; Gangal SG
    Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells.
    Rohrer JW; Rohrer SD; Barsoum A; Coggin JH
    J Immunol; 1994 Jan; 152(2):754-64. PubMed ID: 7904290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced growth of fibrosarcoma in mice treated with phytohemagglutinin.
    Wagener DJ
    Cancer Res; 1973 Jun; 33(6):1295-300. PubMed ID: 4718679
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.